LDHA and non-small cell lung carcinoma: EphA2 was shown also to promote growth, invasion, and survival of non-small-cell lung cancer (NSCLC) stem cell-like populations (enriched for the Aldehyde Dehydrogenase activity, ALDH) [150] by increasing the levels of p-JNK.